Cintia Piccina
Patrimonio netto: 666 $ in data 31/05/2026
Patrimonio netto: 666 $ in data 31/05/2026
Cintia Piccina formerly worked at Adaptimmune Therapeutics Plc, as Chief Commercial Officer from 2022 to 2023, Adaptimmune Therapeutics Plc, as Chief Commercial Officer, AlloVir, Inc., as Chief Commercial Officer from 2023 to 2024, 2seventy Bio, Inc., as SVP-Commercial Oncology & US General Manager from 2021 to 2022, and Novartis Pharmaceuticals Corp., as Vice President-Oncology from 1997 to 2020.
Dr. Piccina received her doctorate degree from the University of Sao Paulo and Masters Business Admin degree from Escola Superior de Propaganda e Marketing.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/04/2025 | 666.438 ( 0,04% ) | 666 $ | 31/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
| ALLOVIRPAR | Corporate Officer/Principal | 01/03/2024 |
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 05/03/2023 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | 01/02/2022 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/04/2020 |
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Sao Paulo
University of Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Escola Superior de Propaganda e Marketing
Escola Superior de Propaganda e Marketing Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
AlloVir, Inc.
AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
2seventy Bio, Inc.
2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale